Pharmaceutical Sector Development in Africa: Progress to Date

The African Union’s Pharmaceutical Manufacturing Plan for Africa was established to develop the African pharmaceutical industry, a sector with considerable promise for reducing the burden of disease in Africa. With a projected value of over US$40 billion by the next decade, the sector also has the p...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical medicine 2018-02, Vol.32 (1), p.1-11
Main Authors: Lartey, Paul A., Graham, Alexandra E., Lukulay, Patrick H., Ndomondo-Sigonda, Margareth
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
AIDS
Antibiotics
Biomedical and Life Sciences
Biomedicine
Business plans
Current Opinion
HIV
Human immunodeficiency virus
Industrial development
Investments
Malaria
Manufacturing
Pandemics
Pharmaceutical industry
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Pharmacotherapy
Political economy
Public health
Tropical diseases
Tuberculosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The African Union’s Pharmaceutical Manufacturing Plan for Africa was established to develop the African pharmaceutical industry, a sector with considerable promise for reducing the burden of disease in Africa. With a projected value of over US$40 billion by the next decade, the sector also has the potential to promote economic growth. Additionally, as a technology-based industry it is positioned to advance Africa’s aspiration to transition into a knowledge-based economy. Considerable progress has been made since the development of a business plan for implementing the Pharmaceutical Manufacturing Plan for Africa. This includes initiatives to harmonize medicine regulation on the continent, address human capacity and skills shortages, and to promote cooperation and advocacy in the industry. The promise of the sector has also galvanized countries and regions with manufacturing capacity to harness support for its development. The rate-limiting step in this quest is making funding available to build the needed capacity in infrastructure and in Good Manufacturing Practices, as stipulated by the Pharmaceutical Manufacturing Plan for Africa. A proposed new initiative, the Fund for African Pharmaceutical Development, currently under consideration by the African Union, may provide the boost needed to overcome this final hurdle.
ISSN:1178-2595
1179-1993
DOI:10.1007/s40290-018-0220-3